International Biotechnology Trust as of Sept. 30, 2023
Portfolio Holdings for International Biotechnology Trust
International Biotechnology Trust holds 65 positions in its portfolio as reported in the September 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Amgen (AMGN) | 7.2 | $21M | 79k | 268.75 | |
Incyte Corporation (INCY) | 7.0 | $21M | 359k | 57.76 | |
Gilead Sciences (GILD) | 5.9 | $18M | 234k | 74.95 | |
Intra Cellular Therapies (ITCI) | 5.6 | $17M | 318k | 52.06 | |
BioMarin Pharmaceutical (BMRN) | 4.6 | $14M | 154k | 88.48 | |
Supernus Pharmaceuticals (SUPN) | 4.0 | $12M | 427k | 27.56 | |
Vera Therapeutics Cl A (VERA) | 3.5 | $10M | 758k | 13.69 | |
Biogen Idec (BIIB) | 3.5 | $10M | 40k | 257.06 | |
Harmony Biosciences Hldgs In (HRMY) | 3.5 | $10M | 315k | 32.77 | |
Mirati Therapeutics | 3.2 | $9.4M | 216k | 43.54 | |
Ultragenyx Pharmaceutical (RARE) | 3.0 | $8.9M | 250k | 35.65 | |
Uniqure N.v. Com Eur0.05 SHS (QURE) | 2.8 | $8.3M | 1.2M | 6.71 | |
Aurinia Pharmaceuticals (AUPH) | 2.7 | $8.1M | 1.0M | 7.76 | |
United Therapeutics Corporation (UTHR) | 2.6 | $7.7M | 34k | 225.50 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 2.5 | $7.3M | 21k | 347.74 | |
Regeneron Pharmaceuticals (REGN) | 2.5 | $7.3M | 8.8k | 822.69 | |
Illumina (ILMN) | 2.3 | $6.9M | 51k | 137.28 | |
Alnylam Pharmaceuticals (ALNY) | 2.2 | $6.5M | 37k | 177.10 | |
Amylyx Pharmaceuticals (AMLX) | 1.8 | $5.4M | 295k | 18.30 | |
Krystal Biotech (KRYS) | 1.8 | $5.3M | 46k | 115.96 | |
Karuna Therapeutics Ord | 1.7 | $5.2M | 31k | 169.09 | |
Axsome Therapeutics (AXSM) | 1.4 | $4.1M | 58k | 69.83 | |
Erasca (ERAS) | 1.3 | $3.8M | 1.9M | 1.97 | |
ACADIA Pharmaceuticals (ACAD) | 1.3 | $3.7M | 180k | 20.81 | |
Revance Therapeutics (RVNC) | 1.1 | $3.3M | 289k | 11.46 | |
Neurocrine Biosciences (NBIX) | 1.1 | $3.2M | 29k | 112.45 | |
Sarepta Therapeutics (SRPT) | 1.1 | $3.2M | 27k | 121.16 | |
Rocket Pharmaceuticals (RCKT) | 1.1 | $3.2M | 156k | 20.47 | |
Denali Therapeutics (DNLI) | 1.1 | $3.2M | 154k | 20.60 | |
Astrazeneca Plc Sponsored Sponsored Adr (AZN) | 1.1 | $3.1M | 47k | 67.71 | |
Xenon Pharmaceuticals (XENE) | 1.1 | $3.1M | 92k | 34.12 | |
Crispr Therapeutics Namen Akt (CRSP) | 1.0 | $2.9M | 63k | 45.38 | |
Madrigal Pharmaceuticals (MDGL) | 0.9 | $2.7M | 18k | 145.87 | |
Legend Biotech Corp Sponsored Ads (LEGN) | 0.9 | $2.6M | 38k | 67.14 | |
Halozyme Therapeutics (HALO) | 0.8 | $2.4M | 62k | 38.20 | |
Marinus Pharmaceuticals I Com New (MRNS) | 0.8 | $2.3M | 290k | 8.06 | |
Beigene Sponsored ADR | 0.8 | $2.3M | 13k | 179.65 | |
Jazz Pharmaceuticals Shs Usd (JAZZ) | 0.7 | $2.2M | 17k | 129.37 | |
Mirum Pharmaceuticals (MIRM) | 0.7 | $2.1M | 68k | 31.54 | |
Iovance Biotherapeutics (IOVA) | 0.7 | $2.0M | 445k | 4.55 | |
Ionis Pharmaceuticals (IONS) | 0.7 | $1.9M | 43k | 45.33 | |
Zai Lab Adr (ZLAB) | 0.6 | $1.9M | 79k | 24.29 | |
Genmab -sp Sponsored Ads (GMAB) | 0.5 | $1.6M | 44k | 35.25 | |
Celldex Therapeutics Com New (CLDX) | 0.4 | $1.3M | 48k | 27.49 | |
Cogent Biosciences (COGT) | 0.4 | $1.3M | 135k | 9.73 | |
Dyne Therapeutics (DYN) | 0.4 | $1.2M | 138k | 8.94 | |
Novocure Ord Shs (NVCR) | 0.4 | $1.2M | 74k | 16.13 | |
Amicus Therapeutics (FOLD) | 0.4 | $1.1M | 90k | 12.14 | |
Cytokinetics Inc Common S Com New (CYTK) | 0.4 | $1.1M | 37k | 29.46 | |
Guardant Health (GH) | 0.4 | $1.1M | 37k | 29.62 | |
Insmed (INSM) | 0.3 | $1.0M | 40k | 25.24 | |
Blueprint Medicines (BPMC) | 0.3 | $1.0M | 20k | 50.11 | |
Akero Therapeutics (AKRO) | 0.3 | $935k | 19k | 50.58 | |
Kezar Life Sciences | 0.3 | $831k | 704k | 1.18 | |
Intellia Therapeutics (NTLA) | 0.3 | $758k | 24k | 31.58 | |
Prothena (PRTA) | 0.2 | $723k | 15k | 48.19 | |
Agios Pharmaceuticals (AGIO) | 0.2 | $594k | 24k | 24.73 | |
Beam Therapeutics (BEAM) | 0.2 | $565k | 24k | 24.03 | |
Ventyx Biosciences (VTYX) | 0.2 | $521k | 15k | 34.71 | |
Vir Biotechnology (VIR) | 0.1 | $440k | 47k | 9.36 | |
I-mab Sponsored Ads (IMAB) | 0.1 | $410k | 311k | 1.32 | |
Ptc Therapeutics I (PTCT) | 0.1 | $381k | 17k | 22.39 | |
Arvinas Ord (ARVN) | 0.1 | $334k | 17k | 19.62 | |
Protagonist Therapeutics (PTGX) | 0.1 | $332k | 20k | 16.68 | |
Relmada Therapeutics (RLMD) | 0.0 | $30k | 10k | 3.00 |